|
1
|
Whittle SB, Smith V, Doherty E, Zhao S,
McCarty S and Zage PE: Overview and recent advances in the
treatment of neuroblastoma. Expert Rev Anticancer Ther. 17:369–386.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rogowitz E, Babiker HM, Kanaan M, Millius
RA, Ringenberg QS and Bishop M: Neuroblastoma of the elderly, an
oncologist's nightmare: Case presentation, literature review and
SEER database analysis. Exp Hematol Oncol. 3:202014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Esiashvili N, Goodman M, Ward K, Marcus RB
Jr and Johnstone PA: Neuroblastoma in adults: Incidence and
survival analysis based on SEER data. Pediatr Blood Cancer.
49:41–46. 2007. View Article : Google Scholar
|
|
4
|
Maris JM, Hogarty MD, Bagatell R and Cohn
SL: Neuroblastoma. Lancet. 369:2106–2120. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bosse KR and Maris JM: Advances in the
translational genomics of neuroblastoma: From improving risk
stratification and revealing novel biology to identifying
actionable genomic alterations. Cancer. 122:20–33. 2016. View Article : Google Scholar :
|
|
6
|
Salazar BM, Balczewski EA, Ung CY and Zhu
S: Neuroblastoma, a paradigm for big data science in pediatric
oncology. Int J Mol Sci. 18:182016. View Article : Google Scholar
|
|
7
|
Schneiderman J, London WB, Brodeur GM,
Castleberry RP, Look AT and Cohn SL: Clinical significance of MYCN
amplification and ploidy in favorable-stage neuroblastoma: A report
from the Children's Oncology Group. J Clin Oncol. 26:913–918. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
London WB, Bagatell R, Weigel BJ, Fox E,
Guo D, Van Ryn C, Naranjo A and Park JR: Historical time to disease
progression and progression-free survival in patients with
recurrent/refractory neuroblastoma treated in the modern era on
Children's Oncology Group early-phase trials. Cancer.
123:4914–4923. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Peifer M, Hertwig F, Roels F, Dreidax D,
Gartlgruber M, Menon R, Krämer A, Roncaioli JL, Sand F, Heuckmann
JM, et al: Telomerase activation by genomic rearrangements in
high-risk neuroblastoma. Nature. 526:700–704. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Quinn JJ and Chang HY: Unique features of
long non-coding RNA biogenesis and function. Nat Rev Genet.
17:47–62. 2016. View Article : Google Scholar
|
|
11
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pandey GK and Kanduri C: Long noncoding
RNAs and neuro-blastoma. Oncotarget. 6:18265–18275. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bi S, Wang C, Li Y, Zhang W, Zhang J, Lv Z
and Wang J: lncRNA-MALAT1-mediated Axl promotes cell invasion and
migration in human neuroblastoma. Tumour Biol.
39:10104283176997962017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yarmishyn AA, Batagov AO, Tan JZ, Sundaram
GM, Sampath P, Kuznetsov VA and Kurochkin IV: HOXD-AS1 is a novel
lncRNA encoded in HOXD cluster and a marker of neuroblastoma
progression revealed via integrative analysis of noncoding
tran-scriptome. BMC Genomics. 15(Suppl 9): S72014. View Article : Google Scholar
|
|
15
|
Bevilacqua V, Gioia U, Di Carlo V,
Tortorelli AF, Colombo T, Bozzoni I, Laneve P and Caffarelli E:
Identification of linc-NeD125, a novel long non coding RNA that
hosts miR-125b-1 and negatively controls proliferation of human
neuroblastoma cells. RNA Biol. 12:1323–1337. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pandey GK, Mitra S, Subhash S, Hertwig F,
Kanduri M, Mishra K, Fransson S, Ganeshram A, Mondal T, Bandaru S,
et al: The risk-associated long noncoding RNA NBAT-1 controls
neuroblastoma progression by regulating cell proliferation and
neuronal differentiation. Cancer Cell. 26:722–737. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sahu D, Hsu CL, Lin CC, Yang TW, Hsu WM,
Ho SY, Juan HF and Huang HC: Co-expression analysis identifies long
noncoding RNA SNHG1 as a novel predictor for event-free survival in
neuroblastoma. Oncotarget. 7:58022–58037. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu M, Ohira M, Li Y, Niizuma H, Oo ML, Zhu
Y, Ozaki T, Isogai E, Nakamura Y, Koda T, et al: High expression of
ncRAN, a novel non-coding RNA mapped to chromosome 17q25.1, is
associated with poor prognosis in neuroblastoma. Int J Oncol.
34:931–938. 2009.PubMed/NCBI
|
|
19
|
Christensen LL, True K, Hamilton MP,
Nielsen MM, Damas ND, Damgaard CK, Ongen H, Dermitzakis E, Bramsen
JB, Pedersen JS, et al: SNHG16 is regulated by the Wnt pathway in
colorectal cancer and affects genes involved in lipid metabolism.
Mol Oncol. 10:1266–1282. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cai C, Huo Q, Wang X, Chen B and Yang Q:
SNHG16 contributes to breast cancer cell migration by competitively
binding miR-98 with E2F5. Biochem Biophys Res Commun. 485:272–278.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Duan W, Du L, Jiang X, Wang R, Yan S, Xie
Y, Yan K, Wang Q, Wang L, Zhang X, et al: Identification of a serum
circulating lncRNA panel for the diagnosis and recurrence
prediction of bladder cancer. Oncotarget. 7:78850–78858. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Brodeur GM, Pritchard J, Berthold F,
Carlsen NL, Castel V, Castelberry RP, De Bernardi B, Evans AE,
Favrot M and Hedborg F: Revisions of the international criteria for
neuro-blastoma diagnosis, staging, and response to treatment. J
Clin Oncol. 11:1466–1477. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Z, Yan S, Attayan N, Ramalingam S and
Thiele CJ: Combination of an allosteric Akt Inhibitor MK-2206 with
etoposide or rapamycin enhances the antitumor growth effect in
neuroblastoma. Clin Cancer Res. 18:3603–3615. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Radogna F, Cerella C, Gaigneaux A,
Christov C, Dicato M and Diederich M: Cell type-dependent ROS and
mitophagy response leads to apoptosis or necroptosis in
neuroblastoma. Oncogene. 35:3839–3853. 2016. View Article : Google Scholar
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
26
|
Alarifi S, Ali D, Alkahtani S and Almeer
RS: ROS-mediated apoptosis and genotoxicity induced by palladium
nanoparticles in human skin malignant melanoma cells. Oxid Med Cell
Longev. 2017:84390982017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang JH, Li JH, Shao P, Zhou H, Chen YQ
and Qu LH: starBase: A database for exploring microRNA-mRNA
interaction maps from Argonaute CLIP-Seq and Degradome-Seq data.
Nucleic Acids Res. 39(Suppl 1): D202–D209. 2011. View Article : Google Scholar
|
|
28
|
Bindea G, Mlecnik B, Hackl H, Charoentong
P, Tosolini M, Kirilovsky A, Fridman WH, Pagès F, Trajanoski Z and
Galon J: ClueGO: A Cytoscape plug-in to decipher functionally
grouped gene ontology and pathway annotation networks.
Bioinformatics. 25:1091–1093. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang C, Gong B, Bushel PR, Thierry-Mieg J,
Thierry-Mieg D, Xu J, Fang H, Hong H, Shen J, Su Z, et al: The
concordance between RNA-seq and microarray data depends on chemical
treatment and transcript abundance. Nat Biotechnol. 32:926–932.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
SEQC/MAQC-III Consortium: A comprehensive
assessment of RNA-seq accuracy, reproducibility and information
content by the Sequencing Quality Control Consortium. Nat
Biotechnol. 32:903–914. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Munro SA, Lund SP, Pine PS, Binder H,
Clevert DA, Conesa A, Dopazo J, Fasold M, Hochreiter S, Hong H, et
al: Assessing technical performance in differential gene expression
experiments with external spike-in RNA control ratio mixtures. Nat
Commun. 5:51252014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Su Z, Fang H, Hong H, Shi L, Zhang W,
Zhang W, Zhang Y, Dong Z, Lancashire LJ, Bessarabova M, et al: An
investigation of biomarkers derived from legacy microarray data for
their utility in the RNA-seq era. Genome Biol. 15:5232014.
View Article : Google Scholar
|
|
33
|
Ohtaki M, Otani K, Hiyama K, Kamei N,
Satoh K and Hiyama E: A robust method for estimating gene
expression states using Affymetrix microarray probe level data. BMC
Bioinformatics. 11:1832010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42D:D92–D97. 2014. View Article : Google Scholar
|
|
35
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yan X, Hu Z, Feng Y, Hu X, Yuan J, Zhao
SD, Zhang Y, Yang L, Shan W, He Q, et al: Comprehensive genomic
characterization of long non-coding RNAs across human cancers.
Cancer Cell. 28:529–540. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu PY, Erriquez D, Marshall GM, Tee AE,
Polly P, Wong M, Liu B, Bell JL, Zhang XD, Milazzo G, et al:
Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc
expression and neuroblastoma progression. J Natl Cancer Inst.
106:1062014. View Article : Google Scholar
|
|
39
|
Zhu H, Zeng Y, Zhou CC and Ye W:
SNHG16/miR-216-5p/ZEB1 signal pathway contributes to the
tumorigenesis of cervical cancer cells. Arch Biochem Biophys.
637:1–8. 2018. View Article : Google Scholar
|
|
40
|
Cao X, Xu J and Yue D: lncRNA-SNHG-16
predicts poor prognosis and promotes tumor proliferation through
epigenetically silencing p21 in bladder cancer. Cancer Gene Ther.
25:10–17. 2018. View Article : Google Scholar
|
|
41
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lian D, Amin B, Du D and Yan W: Enhanced
expression of the long non-coding RNA SNHG16 contributes to gastric
cancer progression and metastasis. Cancer Biomark. 21:151–160.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yang F, Zhang L, Huo XS, Yuan JH, Xu D,
Yuan SX, Zhu N, Zhou WP, Yang GS, Wang YZ, et al: Long noncoding
RNA high expression in hepatocellular carcinoma facilitates tumor
growth through enhancer of zeste homolog 2 in humans. Hepatology.
54:1679–1689. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ye JR, Liu L and Zheng F: Long noncoding
RNA bladder cancer associated transcript 1 promotes the
proliferation, migration, and invasion of nonsmall cell lung cancer
through sponging miR-144. DNA Cell Biol. 36:845–852. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Malumbres M and Barbacid M: Cell cycle,
CDKs and cancer: A changing paradigm. Nat Rev Cancer. 9:153–166.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Uryga A, Gray K and Bennett M: DNA damage
and repair in vascular disease. Annu Rev Physiol. 78:45–66. 2016.
View Article : Google Scholar
|
|
47
|
Lu YF, Cai XL, Li ZZ, Lv J, Xiang YA, Chen
JJ, Chen WJ, Sun WY, Liu XM and Chen JB: lncRNA SNHG16 functions as
an oncogene by sponging miR-4518 and up-regulating PRMT5 expression
in glioma. Cell Physiol Biochem. 45:1975–1985. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Winkle M, Kluiver JL, Diepstra A and van
den Berg A: Emerging roles for long noncoding RNAs in B-cell
development and malignancy. Crit Rev Oncol Hematol. 120:77–85.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chandra Gupta S and Nandan Tripathi Y:
Potential of long non-coding RNAs in cancer patients: From
biomarkers to therapeutic targets. Int J Cancer. 140:1955–1967.
2017. View Article : Google Scholar
|
|
50
|
Guttman M and Rinn JL: Modular regulatory
principles of large non-coding RNAs. Nature. 482:339–346. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ferrè F, Colantoni A and Helmer-Citterich
M: Revealing protein-lncRNA interaction. Brief Bioinform.
17:106–116. 2016. View Article : Google Scholar
|
|
52
|
Chen R, Liu Y, Zhuang H, Yang B, Hei K,
Xiao M, Hou C, Gao H, Zhang X, Jia C, et al: Quantitative
proteomics reveals that long non-coding RNA MALAT1 interacts with
DBC1 to regulate p53 acetylation. Nucleic Acids Res. 45:9947–9959.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Chen S, Ma P, Li B, Zhu D, Chen X, Xiang
Y, Wang T, Ren X, Liu C and Jin X: lncRNA CCAT1 inhibits cell
apoptosis of renal cell carcinoma through up-regulation of Livin
protein. Mol Cell Biochem. 434:135–142. 2017. View Article : Google Scholar : PubMed/NCBI
|
